Angeliki Chalkiadaki

Angeliki Chalkiadaki, PhD, currently serves as Innovation Program Manager at Syntis Bio since September 2025. Previously, from September 2021 to May 2025, Angeliki was Principal Scientist in Discovery and Translational Oncology at ARase Therapeutics, where notable achievements included leading oncology programs, developing biochemical assays, managing efficacy studies, and spearheading data infrastructure initiatives. Prior experience includes roles at Cellarity as Group Lead in Metabolism and Senior Scientist, contributing to early-stage drug discovery in metabolic diseases and managing research teams. Angeliki held a Senior Research Scientist position at the Wyss Institute at Harvard University and a Research Scientist role at the Massachusetts Institute of Technology, focusing on obesity, inflammation, and ovarian cancer. Educational qualifications include a PhD, Master’s, and Bachelor’s degrees in Molecular Biology and Biomedicine and Biology from the University of Crete. Angeliki has also worked as a Scientific Editor for Nature Publishing Group.